PUMA BIOTECHNOLOGY, INC. Business Finance Contracts & Agreements
30 Contracts & Agreements
- Loan Agreements (8 contracts)
- Note Agreements (7)
- Purchase Agreements (4)
- Registration Rights Agreements (3)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- Seventh Amendment to Note Purchase Agreement and Third Amendment to Disclosure Letter, dated April 12, 2024, by and between the Company and Athyrium Opportunities IV CO-Invest 1... (Filed With SEC on May 2, 2024)
- Sixth Amendment to Note Purchase Agreement, dated September 8, 2023, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on November 2, 2023)
- Limited Waiver and Fifth Amendment to Note Purchase Agreement, dated July 7, 2023, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on August 3, 2023)
- Fourth Amendment to Note Purchase Agreement, dated November29, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 2, 2023)
- Second Amendment to Note Purchase Agreement, dated May 18, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 2, 2023)
- Securities Purchase Agreement, dated December 9, 2022, by and between Puma Biotechnology, Inc. and Alan H. Auerbach (Filed With SEC on December 13, 2022)
- Third Amendment to Note Purchase Agreement, dated September 16, 2022, by and between the Company and Athyrium Opportunities IV Co-Invest 1 LP, as Administrative Agent (Filed With SEC on November 3, 2022)
- First Amendment to Note Purchase Agreement, dated February 8, 2022, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent (Filed With SEC on March 3, 2022)
- Amendment to Warrant to Purchase Shares of Common Stock of Puma Biotechnology, Inc (Filed With SEC on June 17, 2021)
- Fourth Amendment to Amended and Restated Loan and Security Agreement, dated February 3, 2021, by and between the Company and Oxford Finance LLC, as collateral agent and Lender (Filed With SEC on May 6, 2021)
- Third Amendment to Amended and Restated Loan and Security Agreement, dated August 5, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender (Filed With SEC on August 6, 2020)
- Second Amendment to Amended and Restated Loan and Security Agreement, dated July 6, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender (Filed With SEC on August 6, 2020)
- First Amendment to Amended and Restated Loan and Security Agreement, dated February 27, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender (Filed With SEC on March 4, 2020)
- Amended and Restated Loan and Security Agreement, dated June 28, 2019, by and between the Company and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on August 9, 2019)
- Second Amendment to Loan and Security Agreement, dated September 27, 2018, by and among the Company, Silicon Valley Bank, as administrative and collateral agent and lender, and... (Filed With SEC on November 5, 2018)
- First Amendment to Loan and Security Agreement, dated May 8, 2018, by and among the Company, Silicon Valley Bank, as administrative and collateral agent (Filed With SEC on August 9, 2018)
- Loan and Security Agreement dated October 31, 2017, by and among the Company, Silicon Valley Bank, as administrative and collateral agent, and the lenders party thereto from time... (Filed With SEC on March 9, 2018)
- PUMA BIOTECHNOLOGY, INC. (aDelaware corporation) 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 21, 2016)
- PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) 1,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 22, 2015)
- PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) 7,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 24, 2012)
- PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) lShares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 15, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 16, 2011)
- PUMA BIOTECHNOLOGY, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 16, 2011)
- AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 23, 2011)
- PUMA BIOTECHNOLOGY, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on November 23, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 18, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 11, 2011)
- PUMA BIOTECHNOLOGY, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 11, 2011)
- PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on October 11, 2011)
- PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on October 11, 2011)
